Related Experiment Video
Updated: Jan 24, 2026

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017
Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
Seyyed Abolfazl Abolfazli1,2, Mehdi Mohammadzadeh1, Farzad Peiravian1
1Department of Pharmacoeconomics and Pharmacy Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ different modes of strategy-making. It offers a typology of different modes of strategy-making that most likely exist in pharmaceutical companies and hypothesizes how this typology relates to performance. It then describes the results of an empirical study of the strategy-making processes of pharmaceutical companies. The structural equation analysis of the data from 31 pharmaceutical companies indicates that there are simplistic, adaptive, entrepreneurial, participative, and SPACE (Strategy making Process According to Complexity Environment) modes of strategy-making in pharmaceutical companies; of these modes, SPACE mode exhibited a significant relationship with performance.
Related Concept Videos
High-Performance Liquid Chromatography: Elution Process
Pharmaceutical Equivalents
Microorganisms in Agriculture and Food industry
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

